April, 2024
April 2024
Lisa Newman Awarded the 2024 ASCO Gianni Bonadonna Breast Cancer Award
Mar 26, 2024, 18:39

Lisa Newman Awarded the 2024 ASCO Gianni Bonadonna Breast Cancer Award

The American Society of Clinical Oncology (ASCO) has announced Lisa Newman, MD, MPH, FASCO, as the recipient of the 2024 ASCO Gianni Bonadonna Breast Cancer Award. This award acknowledges Dr. Newman’s dedication and contributions to the field of global oncology.

Dr. Lisa Newman is a surgical oncologist with a practice dedicated to breast cancer management. In August 2018 she was appointed to oversee the breast program for the Weill Cornell Medicine-New York Presbyterian Hospital Network, serving its Manhattan, Queens and Brooklyn sites. Previously, she worked at the Henry Ford Health System, where she served as breast program director, covering multiple hospitals throughout Michigan since 2015. She is also the Founding Medical Director for the International Center for the Study of Breast Cancer Subtypes, which became headquartered at Weill Cornell Medicine with Dr. Newman’s recruitment.

Dr. Newman holds a Master’s Degree in Public Health from Harvard University, and she also obtained her undergraduate education at Harvard University with a major in chemistry. She attended medical school and completed her general surgery residency training at the State University of New York Downstate Medical Center in Brooklyn. Dr. Newman was recruited to remain at Downstate following completion of her postgraduate training, and served as an Assistant Professor of Surgery with this program for several years. She pursued fellowship training in surgical oncology at the M.D. Anderson Cancer Center 1997-99, followed by joining the faculty as an Assistant Professor; she continues to hold an Adjunct Professorship with M.D. Anderson. After leaving the University of Michigan she was appointed Adjunct Professor in the UM Department of Obstetrics and Gynecology. She also served previously as Associate Director for the Walt Breast Center at Wayne State University/Karmanos Cancer Institute for two years.

Dr. Newman’s primary research has focused on ethnicity-related variation in breast cancer risk and outcome, the evaluation and management of high-risk patients. Her extensive research related to disparities in breast cancer risk and outcome has been published in numerous peer-reviewed medical journals and was featured in CNN’s documentary “Black in America 2”. She has also been the featured breast cancer medical expert for NBC’s “Today Show” twice (2014 and 2017) as well on CBS Nightly News (2015). Dr. Newman’s editorial board service includes: Annals of Surgical Oncology (Breast Section Editor); Cancer (Disparities Section Editor); Journal of Clinical Oncology (Breast Section editorial board member) and she is currently of the editorial board for JAMA Surgery.

About the 2024 ASCO Gianni Bonadonna Breast Cancer Award

First presented in 2007, this award was created to honor the profound contributions of Dr. Gianni Bonadonna, who made several pioneering contributions to the field of oncology. The award recognizes an active clinical and/or translational researcher with a distinguished record of accomplishments in advancing the field of breast cancer and with exceptional mentoring abilities. The research conducted by the award recipient should have had a practice-altering effect on the field of breast cancer diagnosis or treatment.

The oncology community and our team at OncoDaily extend our congratulations to Dr. Lisa Newman on this deserving acknowledgment, which highlights her significant impact on ethnicity-related variation in breast cancer risk.